EMA — authorised 21 November 2016
- Marketing authorisation holder: Takeda Pharma A/S
- Status: approved
🇪🇺 Ninlaro in European Union
EMA authorised Ninlaro on 21 November 2016
Marketing authorisation
Ninlaro in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Ninlaro approved in European Union?
Yes. EMA authorised it on 21 November 2016.
Who is the marketing authorisation holder for Ninlaro in European Union?
Takeda Pharma A/S holds the EU marketing authorisation.